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Does injection of steroids
and lidocaine in the shoulder
relieve bursitis?
■ EVIDENCE-BASED ANSWER
Subacromial steroid injection may provide a
small, short-term benefit compared with placebo.
The short-term effectiveness of steroid injection
compared with nonsteroidal anti-inflammatory
agents (NSAIDs) remains unclear. 
Steroid injections are better than physiothera-
py alone in the short term. However, injection
does not appear to provide any meaningful long-
term benefit compared with other therapies
(strength of recommendation: B). Data are insuf-
ficient to make recommendations regarding the
proper timing of injection in the sequence of other
treatments. Side effects of steroid injection, such
as steroid flare and infection, are rare.
■ EVIDENCE SUMMARY
A Cochrane Review of corticosteroid injections
for shoulder pain found 7 randomized controlled
trials comparing subacromial steroid injections
with placebo.1 The placebos were either
injectable anesthetics alone or injectable anes-
thetics combined with oral placebo tablets. Six of
the 7 studies used the anterolateral approach to
inject under the acromion. 
All studies used a clinical exam for diagnosis
that showed pain with range of motion (especial-
ly abduction) or pain that was consistent with
impingement syndrome. Most of the follow-up
times were short, typically 4 to 12 weeks, and the
longest study was 33 weeks. Meta-analyses often
report the effect size using standard mean differ-
ence (SMD). A rule of thumb for interpretation of
SMD is a value of 0.2 indicates a small effect, a
value of 0.5 indicates a medium effect, and a
value of 0.8 or larger indicates a large effect. If
the 95% confidence interval [CI] does not include
zero, then the SMD is statistically significant at
the 5% level (P<.05).2
Two of the studies comparing steroid injection
with placebo were methodologically suitable for
meta-analysis; these studies showed that
steroids provided a mild, short-term (4-week)
benefit with respect to pain (SMD=0.83; 95% CI,
0.39–1.26), function (SMD=0.63; 95% CI,
0.20–1.06), and abductive range of motion
(SMD=0.82; 95% CI, 0.39–1.25).3,4
Results of the remaining, less rigorous trials
were conflicting and inconclusive. The reviewers
also found 3 randomized controlled trials com-
paring subacromial steroid injection with oral
NSAIDs. The pooled results of these trials,
encompassing 120 patients, found no differences
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(1966–1995) and EMBASE (1984–1995) and
found 16 articles that met qualifying conditions
for further review. Of these, 3 were methodologi-
cally adequate for final review. None of these 
3 studies provided evidence showing the efficacy
of steroid injections. The results of the major 
trials reviewed can be found in the Table. 
■ RECOMMENDATIONS FROM OTHERS
The American Academy of Orthopaedic Surgeons’
clinical guideline for shoulder pain9 recommends
the following for rotator cuff disease: avoidance of
irritating activity; anti-inflammatory medications
if tolerated; exercises to recover and maintain
passive range of motion; exercises to strengthen
the rotator cuff once acute symptoms abated. If
these are unsuccessful over several weeks, they
recommend considering subacromial injection of
local anesthetic and a short-acting corticosteroid.
They gave their recommendation a “B” rating
(some evidence exists to suggest benefit). 
Greg Gutierrez, MD, Denver Health and Hospital, Denver,
Colo; Martha Burroughs, MLS, University of Colorado
Health Sciences Center, Denver
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in these 3 outcomes at 4 or 6 weeks. The review
of an additional trial of 50 patients comparing
subacromial steroid injection plus simultaneous
oral NSAIDs with oral NSAIDs alone found no dif-
ferences at 4 weeks. All 11 studies had small
sample sizes, and suffered from variable method-
ological quality and heterogeneous results. 
The reviewers concluded that steroids are
probably better than placebo but provide little or
no benefit in addition to NSAIDs, and that evi-
dence is insufficient to guide treatment.
Likewise, a Cochrane Review of multiple inter-
ventions for shoulder pain also found “little evi-
dence to support or refute the efficacy of common
interventions” and highlighted the need for new,
well-designed trials.5
Another Cochrane Review examined 4 ran-
domized controlled trials comparing physiothera-
py interventions for shoulder pain.6 They found
that steroid injections may be superior to physio-
therapy for rotator cuff disease, but the type of
physiotherapy and injection sites were not con-
sistent across the studies, making creation of
summary estimates inappropriate. The individual
studies showed significant short-term benefits
(3–7 weeks) of steroid injection over physiother-
apy; however, long-term (6–52 weeks) benefits
ranged from some benefit to no difference. These
studies were consistent regarding age (mean
age=53–55 years, SD ± 13–14 years) and com-
plications reported, with the only side effect
being postinjection soreness. 
Hay et al7 conducted a multicenter, primary
care–based randomized controlled trial with more
than 200 patients, which was published too
recently for inclusion in the Cochrane Review.
They found no statistical difference in improve-
ment between steroid injection without physio-
therapy and physiotherapy alone at 6 weeks. 
In 1996, van der Heijden et al8 systematically
reviewed randomized clinical trials of steroid
injections for shoulder disorders, including rota-
tor cuff disease, adhesive capsulitis, rheumatoid
conditions, and periarthritis. They screened more
than 200 articles from searches in Medline
Subacromial steroid injections 
are better than physiotherapy alone
in the short term
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Major placebo-controlled trials of injectable steroids 
for shoulder pain 
Follow-up 
Steroid (n) Comparison arms (n) Reported results Conclusions
Methylprednisolone 1% lignocaine 12 wks 2 wks: insignificant No significant
1% lignocaine (28) (28) improvement in steroid advantage of
arm subacromial methyl
2, 4, 6, 12 wks: no prednisolone 
difference in pain, range over lignocaine10
of motion; all P>.05
Triamcinolone, C1: diclofenac, 4 wks 4 wks: steroid and C1  Triamcinolone and 
0.5% lignocaine, lignocaine (20) showed significant benefit diclofenac are 
placebo tabs (20) C2: placebo tabs, over C2 for pain and range equivalent, and 
lignocaine (20) of motion (P<.05) superior to placebo3
Steroid vs C1: no 
difference (P=.0268)
S1: triamcinolone, C1: 1% lidocaine, 4 wks S1 superior to S2, C1, C2 Triamcinolone and 
1% lidocaine, naproxen (25) S2 superior to C1, C2 naproxen superior to
naproxen (25) C2: 1% lidocaine, For pain and clinical index placebo. More severe
S2: triamcinolone, placebo (25) at 2 and 4 wks, P<.05 cases see most
1% lidocaine, benefit4
placebo (25)
Triamcinolone, Saline injection, 6 wks Pain and global scores No difference
placebo tabs (15); indomethacin (15); improved in both groups between
reinjection at 3 wks reinjection at (P<0.05), but no difference indomethacin and
if not better 3 wks if not between them (P>.05) triamcinolone
better injection11
S1: methylprednisolone, C1: acupuncture 4 wks All patients improved. Painful stiff shoulder
lidocaine, placebo tabs (12) (12) No differences in pain may be self-limiting
S2: methylprednisolone, C2: ultrasound (12) scores or abduction condition and bene-
NSAID (12) C3: placebo tab, measurements at 2 or ficial effect may be
placebo U/S (12) 4 wks (P=n/a) natural recovery12
Methylprednisolone, Physiotherapy 6 mos, No differences in Physiotherapy and 
1% lidocaine (104) (103) option of other disability scores steroid injection were
therapies given 6 wks: mean difference= of similar short- and
at 6 weeks –.05 (95% CI, –.02 to 3.0) long-term effectiveness
6 mos: mean difference= for treating new 
1.4 (95% CI, –0.2 to 3.0) (7) episodes of unilateral 
shoulder pain
Triamcinolone, 1% lidocaine (21) Mean: 33 wk; Steroid: significant Subacromial injection 
1% lidocaine (19) range: 12–52 wk improvements of pain of steroids is effective
(P<.005) and range of motion for short-term therapy
(P<.005) vs control. No of impingement
difference in activities of syndrome
daily living seen (13)
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What treatments are safe
and effective for mild 
to moderate hypertension 
in pregnancy?
■ EVIDENCE-BASED ANSWER
There is considerable debate concerning the treat-
ment of mild to moderate essential hypertension
during pregnancy. Evidence suggests that
because of the potential risk of fetal intrauterine
growth restriction, treatment of hypertension
should be delayed until maternal blood pressure
reaches 150–160 mm Hg systolic or 100–110 
mm Hg diastolic, as long as the mother has no
preexisting end organ damage.
Methyldopa has been the drug of choice for oral
treatment, as it is the only medication to have any
extended follow-up study. However, a recent meta-
analysis raised the possibility of increased fetal
mortality (strength of recommendation [SOR]: A,
based on systematic review of randomized con-
trolled trials). 
Labetalol is an effective alternative, but 
concerns remain that treatment with any beta-
blocker increases the risk that infants will be
small for gestational age (SGA) (SOR: B, based on
small randomized controlled trials with inconsis-
tent results). 
There is limited evidence that calcium channel
blockers and diuretics are safe alternatives,
although evidence is insufficient to prove a clear
benefit (SOR: B, based on limited randomized 
controlled trials). Angiotensin-converting enzyme
(ACE) inhibitors and angiotensin receptor block-
ers (ARBs), due to similar mechanisms of action,
are contraindicated in pregnancy (SOR: B, based
on multiple case studies). No other class of anti-
hypertensive medications is proven to be harmful
in pregnancy.
■ EVIDENCE SUMMARY
Treatment of maternal hypertension during preg-
nancy is based on maternal and fetal outcomes.
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■ CLINICAL COMMENTARY:
Consider injection with anesthetic 
and steroid for rotator cuff impingement
Subacromial injection is an integral compo-
nent of the treatment armamentarium for cer-
tain types of shoulder pathology. Diagnostically,
injection of a local anesthetic such as lido-
caine can help differentiate true weakness
caused by a full-thickness rotator cuff tear
from inhibition due to inflammation and
impingement pain. Strongly consider subacro-
mial injection with both a local anesthetic
and corticosteroid for patients with true rota-
tor cuff impingement as diagnosed by positive
Neer and Hawkins signs on examination. 
If injection is appropriately administered, the
patient should have near-immediate and sig-
nificant reduction of impingement symptoms.
They may regain motion sooner and advance
quicker through their initial therapy program.
Sourav Poddar, MD, Team Physician, University of
Colorado Buffaloes, University of Colorado Health Sciences
Center, Denver
